Search

Filters
Clear All
  • 11
  • 46
  • 1
  • 564

Phase

  • 9
  • 7
  • 41
  • 6
  • 68
  • 6
  • 477
  • 557
  • 282

Found 622 in-health trials

A listing of in-health medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

J
James Croop, MD, PhD
1 years - 21 years
All genders
This study is designed to investigate whether the use of copanlisib is safe, feasible and beneficial to pediatric patients with solid solid tumors or lymphoma that are recurrent or refractory to standard therapy.
N
Noel Dasgupta
18 years or above
All genders
Phase 3
Interventional
The purpose of this study is to evaluate the safety and tolerability of extended dosing withwith hereditary transthyretin-mediated amyloid polyneuropathy (hATTR-PN).
J
John DeWitt, MD
18 years - 85 years
All genders
Phase 2
Interventional
What is the goal of this study?The goal of this clinical trial is to test the safety and effectiveness of a single dose of RABI-767 given by endoscopic ultrasound (EUS) guided peripancreatic injection in participants with predicted severe acute pancreatitis.The main question the study aims to answer is:• Is a …
M
Mark Gromski, MD
21 years - 100 years
All genders
Interventional
What is the purpose of this study?The REMAIN-1 clinical trial is a prospective, pivotal, double-blind, randomized, sham-controlled trial that will investigate the superiority of Revita DMR compared with sham on the maintenance of weight loss after successfully losing at least 15% total body weight on an open-label, dose escalation, tirzepatide …
V
Vijaya L. Kakani, MD
18 years - 100 years
All genders
Phase 3
Interventional
What is the purpose of this study?This study will assess if adding sacituzumab tirumotecan with pembrolizumab after surgery is effective in treating NSCLC for participants not achieving pathological complete response. The primary hypothesis of this study is sacituzumab tirumotecan plus pembrolizumab is superior to pembrolizumab monotherapy with respect to disease …
18 years - 100 years
All genders
The purpose of this study is to find out what effects, good and/or bad, there are to adding the drug ramucirumab (RAM) to the usual chemotherapy regimen.
J
Jared Brosch, MD
18 years - 100 years
All genders
Phase 1
Interventional
Who is Eligible Ages 18+ Must have had symptoms of Alzheimer’s disease prior to age 65 Diagnosis of Alzheimer’s disease Must be able to complete MRI Must be able to tolerate lumbar puncture No history of seizures, stroke or cancer in the last 5 years What is Involved In-person visits …
J
John Fuqua, MD
2 years - 10 years
All genders
Phase 3
Interventional
The study compares two medicines for treatment of children born small and who stay small, or with Turner Syndrome, Noonan Syndrome, or idiopathic short stature. The purpose of the studyhow well treatment with somapacitan works compared to treatment with Norditropin®.w medicine, and Norditropin® is a medicine doctors can already prescribeuntries. …
N
Naga Chalasani, MD
18 years - 80 years
All genders
Observational
Nonalcoholic fatty liver disease (NAFLD) is a spectrum of liver conditions associated withumulation that ranges from benign, non-progressive liver fat accumulation to severever injury, cirrhosis, and liver failure. NAFLD is the most common liver disease in USdults and the second leading cause for liver transplantation in the US. The natural …
T
Troy Markel, MD
2 years - 100 years
All genders
Interventional
What is the purpose of this study?To evaluate the efficacy of TachoSil versus Surgicel Original for control of soft tissue local mild (Grade 1) to moderate (Grade 2) bleeding (according to the VIBe Scale) in participants undergoing abdominal, retroperitoneal, pelvic, or thoracic surgery THIS STUDY IS ENROLLING BY INVITATION ONLY
591 - 600 of 622